miR-31 controls osteoclast formation and bone resorption by targeting RhoA
Department of Medicine and Rheumatology, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University, 1-5-45 Yushima, Bunkyo-ku, Tokyo 113-8519, Japan
Arthritis Research & Therapy 2013, 15:R102 doi:10.1186/ar4282Published: 3 September 2013
Additional file 1:
Figure S1 showing real-time PCR analysis of osteoclasts generated under miR-31 inhibition. Values were normalized to U6B expression. Expression levels of miR-21, miR-155 and miR-223 were not altered by miR-31 inhibitions (n = 3/group).
Format: PDF Size: 90KB Download file
This file can be viewed with: Adobe Acrobat Reader